Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL598304 | 0.92 | — | — | |
| SCHEMBL2563360 | 0.87 | TSHR (0.33) | TSHRTDP1LMNAHSD17B10 | |
| SCHEMBL6988533 | 0.85 | LMNA (0.32) | TSHRTDP1LMNAHSD17B10 | |
| SCHEMBL11494581 | 0.85 | TSHR (0.37) | TSHR | |
| SCHEMBL12985778 | 0.85 | LMNA (0.37) | TSHRTDP1LMNAHSD17B10 | |
| SCHEMBL24484743 | 0.85 | LMNA (0.37) | TSHRTDP1LMNAHSD17B10 | |
| SCHEMBL19003065 | 0.85 | LMNA (0.37) | TSHRTDP1LMNAHSD17B10ALDH1A1 | |
| SCHEMBL16286978 | 0.84 | LMNA (0.42) | TSHRTDP1LMNAHSD17B10ALDH1A1 | |
| SCHEMBL17695964 | 0.81 | — | — | |
| SCHEMBL17277220 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | SUPER CRITICAL IP, LLC (US) | 2026-05-05 | — | — | US | disclosed |
| US-20250152646-A1 | SOLVENTS, METHODS, AND SYSTEMS FOR ISOLATING CANNABINOIDS FROM PLANTS EXTRACTS OR FROM SYNTHETIC PATHWAYS | NOEL ARMAND J (US) | 2025-05-15 | — | — | US | disclosed |
| US-12090185-B2 | Processes for converting cannabinoids into cannabinoid derivatives and recovering the same | SUPER CRITICAL IP, LLC (US) | 2024-09-17 | — | — | US | disclosed |
| EP-3907003-B1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF AS CATALYST LIGAND IN ETHYLENE OLIGOMERIZATION | CHINA PETROLEUM & CHEM CORP (CN) | 2024-09-04 | — | — | EP | disclosed |
| US-20240082335-A1 | PROCESSES AND SYSTEMS FOR CONVERTING CANNABINOIDS INTO CANNABINOID DERIVATIVES AND ISOLATING THE SAME | SUPER CRITICAL IP, LLC | 2024-03-14 | — | — | US | disclosed |
| US-11872259-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | SUPER CRITICAL IP, LLC (US) | 2024-01-16 | — | — | US | disclosed |
| US-11826743-B2 | Halogen-containing compound and use thereof as catalyst ligand in ethylene oligomerization | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2023-11-28 | — | — | US | disclosed |
| US-11759491-B2 | Solvents, methods, and systems for isolating botanical extracts from plants | SUPER CRITICAL IP, LLC (US) | 2023-09-19 | — | — | US | disclosed |
| EP-3907004-B1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF, CATALYST COMPOSITION, AND ETHYLENE OLIGOMERIZATION, TRIMERIZATION AND TETRAMERIZATION METHODS | CHINA PETROLEUM & CHEM CORP (CN) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023009954-A1 | SOLVENTS, METHODS, AND SYSTEMS FOR ISOLATING BOTANICAL EXTRACTS FROM PLANTS | NOEL ARMAND J (US) | 2023-02-02 | — | — | WO | disclosed |
| WO-2003051298-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003051306-A2 | N4-ACYLCYTOSINE-1,3-DIOXOLANE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| WO-2002101307-A1 | NATURAL GAS LIQUEFACTION | ELKCORP (US) | 2002-12-19 | — | — | WO | disclosed |
| WO-2002086404-A1 | LNG PRODUCTION IN CRYOGENIC NATURAL GAS PROCESSING PLANTS | ELCOR CORPORATION (US) | 2002-10-31 | — | — | WO | disclosed |
| WO-2002014242-A1 | HYDROCARBON GAS PROCESSING | ELCOR CORPORATION (US) | 2002-02-21 | — | — | WO | disclosed |
| EP-1137903-A1 | HYDROCARBON GAS PROCESSING | ELCOR CORPORATION (US) | 2001-10-04 | — | — | EP | disclosed |
| WO-2000033006-A1 | HYDROCARBON GAS PROCESSING | ELCOR CORPORATION (US) | 2000-06-08 | — | — | WO | disclosed |
| EP-0937016-A1 | HYDROCARBON GAS PROCESSING | ELCOR CORPORATION (US) | 1999-08-25 | — | — | EP | disclosed |
| US-5881569-A | Hydrocarbon gas processing | ELCOR CORPORATION (US) | 1999-03-16 | — | — | US | disclosed |
| WO-1998017609-A1 | HYDROCARBON GAS PROCESSING | ELCOR CORPORATION (US) | 1998-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | CNR2, CNR1, SCD | TSHR 2794/4885TDP1 4427/4885LMNA 408/4885 |
| US-11826743-B2 | Halogen-containing compound and use thereof as catalyst ligand in ethylene oligomerization | NOD1, C9, NOD2 | TSHR 613/4885TDP1 1497/4885LMNA 3051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.